Skip to main content
. 2018 Aug 12;2018:9305294. doi: 10.1155/2018/9305294

Table 2.

Currently recruiting clinical trials of intratumoral immunotherapy in soft tissue sarcoma.

Treatment Phase ClinicalTrials.gov identifier
HSV-1 M002 (IT or IV) I NCT00931931
HSV-1 M002 + concurrent radiation I/II NCT02453191
HSV-1 M002 + pembrolizumab II NCT03069378
TVEC + preoperative radiation I/II NCT02453191
JX-594 + cyclophosphamide I/II NCT02630368
TTI-621 I NCT02890368
INTUVAX I NCT02686944
Poly-ICLC II NCT01984892
Clostridium novyi-NT spores I NCT01924689